https://inseptiongroup.com/2022/07/inseption-group-5m/ 2025-08-05T04:19:26+00:00 weekly 0.8 https://inseptiongroup.com/2022/07/inseption-group-2-minute-video/ 2025-08-05T04:19:07+00:00 weekly 0.8 https://inseptiongroup.com/2023/02/tmf/ 2025-08-01T03:53:58+00:00 weekly 0.8 https://inseptiongroup.com/2023/03/cmo-testimonials/ 2025-08-05T04:18:42+00:00 weekly 0.8 https://inseptiongroup.com/2023/04/what-is-quality/ 2025-07-31T14:06:09+00:00 weekly 0.8 https://inseptiongroup.com/2023/09/inseption-group-video-2023/ 2025-08-04T17:45:16+00:00 weekly 0.8 https://inseptiongroup.com/2024/03/sqa-2024/ 2025-08-05T14:52:14+00:00 weekly 0.8 https://inseptiongroup.com/2024/04/the-cooperativity-program-2024/ 2025-07-31T13:59:32+00:00 weekly 0.8 https://inseptiongroup.com/2024/04/cmo-testimonials-2/ 2025-08-05T04:18:04+00:00 weekly 0.8 https://inseptiongroup.com/2025/04/site-relationship-strategy-ensuring-quality-data-and-study-performance/ 2025-08-04T02:27:00+00:00 weekly 0.8 https://inseptiongroup.com/2025/04/leveraging-clinical-trial-data-in-real-time-to-effect-change-and-mitigate-risk/ 2025-05-30T14:32:50+00:00 weekly 0.8 https://inseptiongroup.com/2025/04/how-sponsors-and-patients-benefit-from-a-site-centric-partnership/ 2025-08-05T04:17:36+00:00 weekly 0.8 https://inseptiongroup.com/2025/04/how-biostatistics-can-help-your-business/ 2025-04-22T18:25:29+00:00 weekly 0.8 https://inseptiongroup.com/2025/04/the-critical-role-of-the-medical-monitor-in-a-clinical-study/ 2025-08-04T02:17:46+00:00 weekly 0.8 https://inseptiongroup.com/2025/04/gap-analysis-and-collaboration-lead-to-success/ 2025-08-04T02:20:22+00:00 weekly 0.8 https://inseptiongroup.com/2025/04/shifting-the-approach-4-strategies-for-ich-e6r3-implementation/ 2025-08-06T04:04:43+00:00 weekly 0.8 https://inseptiongroup.com/2025/04/evolving-trial-master-files-require-experienced-tmf-resourcing/ 2025-10-30T01:19:21+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/quality-control-in-medical-writing-what-it-means-and-why-it-matters/ 2025-08-06T04:14:05+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/diverse-mentorship-models-create-multiple-paths-to-employee-success/ 2025-08-04T02:28:06+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/how-inseption-unlocked-the-secret-to-repeatable-scalable-low-turnover/ 2025-10-16T13:07:09+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/a-prescription-for-success-treating-deficiencies-in-employee-training-and-mentoring/ 2025-10-16T13:07:26+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/is-a-multitherapeutic-contract-research-partner-the-best-fit-for-your-clinical-trial/ 2025-05-30T13:52:48+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/natural-history-studies-in-gene-therapy-trials-benefits-timing-and-execution/ 2025-08-05T04:16:48+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/the-great-talent-misconception-with-large-cros/ 2025-08-04T01:43:50+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/keys-to-successful-risk-management-in-clinical-trials/ 2025-08-04T02:10:28+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/do-you-take-comfort-in-governance-agreements/ 2025-08-04T02:07:32+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/the-fallacy-of-the-corporate-memory-concept/ 2025-08-04T02:06:24+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/what-big-cros-dont-want-you-to-know-about-staffing-scalability-for-phase-iii-studies/ 2025-08-04T02:05:12+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/great-size-%e2%89%a0-great-value-how-smaller-outsourcing-partners-benefit-small-and-emerging-biotechs/ 2025-08-04T02:03:37+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/identifying-the-best-people-to-run-a-clinical-study-and-how-to-hire-them/ 2025-08-06T03:59:40+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/modernize-tmf-culture-to-better-support-modern-clinical-trials/ 2025-08-06T04:02:35+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/top-5-considerations-for-car-t-trials-during-a-macroeconomic-downturn/ 2025-08-06T04:08:01+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/why-the-regional-site-manager-is-the-swiss-army-knife-of-clinical-trial-monitoring/ 2025-11-16T12:45:52+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/rare-disease-clinical-endpoints-ingenuity-meets-practicality/ 2025-08-04T01:53:03+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/second-times-the-charm-navigating-nda-submission-plus-a-resubmission-rescue-mission/ 2025-10-16T13:06:54+00:00 weekly 0.8 https://inseptiongroup.com/2025/05/how-to-establish-effective-scalable-drug-safety-ops-across-multiple-vendors/ 2025-08-04T01:53:48+00:00 weekly 0.8 https://inseptiongroup.com/2025/06/whats-wrong-with-my-trial-uncovering-the-root-cause-of-clinical-trial-troubles/ 2025-08-04T01:54:11+00:00 weekly 0.8 https://inseptiongroup.com/2025/06/slow-the-burn-how-to-make-risk-resilient-vendor-choices/ 2025-08-04T01:54:34+00:00 weekly 0.8 https://inseptiongroup.com/2025/07/successful-regulatory-submission-via-the-trifecta-of-awesomeness/ 2025-10-29T22:01:43+00:00 weekly 0.8 https://inseptiongroup.com/2025/07/is-a-multitherapeutic-contract-research-partner-the-best-fit-for-your-clinical-trial-2/ 2025-08-05T03:58:56+00:00 weekly 0.8 https://inseptiongroup.com/2025/07/how-sponsors-and-patients-benefit-from-a-site-centric-partnership-2/ 2025-08-04T01:52:01+00:00 weekly 0.8 https://inseptiongroup.com/2025/07/risk-based-monitoring-rbm/ 2025-08-04T01:51:02+00:00 weekly 0.8 https://inseptiongroup.com/2025/07/fda-update-on-ich-e6-e8-qbd-and-rbm-in-clinical-trials/ 2025-08-04T01:50:38+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/cmo-summit-360-partner/ 2025-08-12T18:35:37+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/karin-rezzonico/ 2025-08-03T07:40:21+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/raul-p-lima/ 2025-08-03T07:38:51+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/crissy-reynolds/ 2025-08-03T03:08:21+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/cras-must-evolve-alongside-oncology-therapeutics/ 2025-08-04T01:51:40+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/rare-disease-clinical-endpoints-ingenuity-meets-practicality-2/ 2026-02-26T16:26:46+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/jenny-minigh/ 2025-08-04T01:48:22+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/high-velocity-development-gene-therapy-vs-small-molecule/ 2025-08-04T01:51:15+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/how-to-build-effective-clinical-trial-oversight-and-leadership/ 2025-12-01T03:26:42+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/dawn-niccum/ 2025-08-04T02:33:10+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/lori-buckenmyer/ 2025-08-04T02:36:43+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/philadelphia-business-journals-fast-50-growing-companies-2024/ 2025-08-05T04:24:18+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/entrepreneur-of-the-year/ 2025-08-05T15:02:30+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/dawn-chair-elect-sqa/ 2025-08-05T04:37:01+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/recovering-a-clinical-trial-that-has-been-derailed/ 2025-10-29T22:04:37+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/pennsylvania-biotechnology-center-partner/ 2025-08-06T03:27:34+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/philadelphia-business-journals-2025-best-places-to-work/ 2025-08-06T03:55:08+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/slow-the-burn-how-to-mitigate-financial-risk-before-selecting-an-outsourcing-vendor/ 2025-10-22T12:50:45+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/the-write-side-of-ai-helping-hands-not-replacement-plans/ 2025-08-12T01:54:57+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/clinical-research-considerations-for-rare-disease-patients-part-2-the-impact-of-physician-and-site-support/ 2025-08-12T02:08:43+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/clinical-research-considerations-for-rare-disease-patients-part-1-reinvigorate-patient-centricity/ 2025-08-12T02:09:16+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/time-logistics-and-manufacturing-in-autologous-cell-therapy-clinical-trials/ 2025-08-12T02:12:42+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/why-site-and-partner-communications-are-critical-to-autologous-cell-therapy-clinical-trials/ 2025-08-12T02:14:22+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/remote-clinical-trial-monitoring-cra-success-in-an-era-of-autonomy/ 2025-08-12T03:00:42+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/why-collaborative-protocol-design-is-vital-to-autologous-cell-therapy-clinical-trials/ 2025-11-16T12:45:31+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/leveraging-clinical-trial-data-in-real-time-to-effect-change-and-mitigate-risk-2/ 2025-08-12T03:05:04+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/strategies-for-a-more-secure-outsourcing-bottom-line/ 2025-12-09T16:59:41+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/outsourcing-vendor-red-flag-3-a-bid-is-inaccurate-or-suspiciously-low/ 2025-08-12T03:12:26+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/outsourcing-vendor-red-flag-2-layers-of-oversight-and-process-are-impeding-my-program/ 2025-10-29T22:04:08+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/outsourcing-vendor-red-flag-1-copy-and-paste-bids-cookie-cutter-contracts/ 2025-08-12T03:19:29+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/the-great-rehire-finding-your-fit-in-todays-clinical-research-industry/ 2025-08-12T03:22:46+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/is-there-really-less-risk-in-selecting-a-large-cro/ 2025-08-12T03:26:19+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/scientific-advisory-board-announcement/ 2025-08-19T20:16:22+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/reframing-rescue-reinforce-your-clinical-trial-instead-of-rebuilding-it/ 2026-04-01T02:48:56+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/practical-applications-of-ich-e6r3-what-do-we-need-to-do/ 2025-10-22T12:53:55+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/whos-in-charge-of-your-trial-how-to-ensure-effective-oversight-and-leadership/ 2026-04-01T02:49:19+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/safety-at-the-center-the-synergistic-role-of-drug-safety-in-clinical-trial-operations/ 2025-10-30T02:01:21+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/mastering-the-complexities-of-gene-therapy-document-writing/ 2025-10-22T12:58:12+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/pabc-lunch-learn/ 2025-08-26T13:31:20+00:00 weekly 0.8 https://inseptiongroup.com/2025/08/inseption-group-integrates-precisedox-expanding-global-medical-writing-capabilities/ 2025-08-28T17:18:12+00:00 weekly 0.8 https://inseptiongroup.com/2025/09/cmo-misunderstandings-about-clinical-operations-and-how-to-improve/ 2026-04-01T02:48:33+00:00 weekly 0.8 https://inseptiongroup.com/2025/09/planning-the-journey-to-your-first-in-human-clinical-study/ 2025-10-30T20:57:13+00:00 weekly 0.8 https://inseptiongroup.com/2025/09/writing-effective-clinical-regulatory-documents-for-gene-therapy-trials/ 2025-10-22T12:36:35+00:00 weekly 0.8 https://inseptiongroup.com/2025/10/philadelphia-100-2025/ 2025-12-11T17:33:43+00:00 weekly 0.8 https://inseptiongroup.com/2025/10/from-crisis-to-confidence-in-medical-writing-ensuring-smooth-regulatory-submissions/ 2025-10-22T12:57:22+00:00 weekly 0.8 https://inseptiongroup.com/2025/10/slow-the-burn-a-deeper-dive-on-how-to-mitigate-financial-risk-before-selecting-an-outsourcing-vendor/ 2025-11-16T12:46:15+00:00 weekly 0.8 https://inseptiongroup.com/2025/10/dispelling-common-clinical-trial-oversight-myths/ 2025-10-30T14:11:28+00:00 weekly 0.8 https://inseptiongroup.com/2025/12/5-medical-writing-best-practices-for-gene-therapy-bla-maa-submissions/ 2025-12-08T18:39:08+00:00 weekly 0.8 https://inseptiongroup.com/2025/12/philadelphia-business-journal-thought-leadership-life-sciences/ 2025-12-08T18:39:30+00:00 weekly 0.8 https://inseptiongroup.com/2025/12/regulatory-submission-crisis-rescue/ 2026-02-06T14:33:12+00:00 weekly 0.8 https://inseptiongroup.com/2025/12/streamlining-clinical-data-management/ 2025-12-11T16:27:59+00:00 weekly 0.8 https://inseptiongroup.com/2025/12/founders-forward-focus-forum-interview-with-joe-arcangelo/ 2025-12-08T18:43:19+00:00 weekly 0.8 https://inseptiongroup.com/2025/12/sqa-board-of-directors/ 2026-02-26T15:13:17+00:00 weekly 0.8 https://inseptiongroup.com/2025/12/fixing-the-monitoring-model-how-a-flexible-resource-supports-trial-success/ 2025-12-15T17:13:28+00:00 weekly 0.8 https://inseptiongroup.com/2025/12/avoid-the-wrecking-ball-targeted-solutions-for-struggling-trials/ 2025-12-15T17:22:55+00:00 weekly 0.8 https://inseptiongroup.com/2026/01/what-to-look-for-in-a-strategic-partner/ 2026-05-18T19:28:27+00:00 weekly 0.8 https://inseptiongroup.com/2026/02/noelle-story/ 2026-02-26T17:59:31+00:00 weekly 0.8 https://inseptiongroup.com/2026/05/charting-the-path-to-first-in-human-studies-strategic-planning-for-early-clinical-success/ 2026-05-18T19:34:59+00:00 weekly 0.8 https://inseptiongroup.com/2026/05/how-to-build-strategic-readiness-for-first-in-human-studies/ 2026-05-18T19:56:43+00:00 weekly 0.8